Indo US BioTech IPO Latest News Today

Track all the latest updates and news of Indo US BioTech IPO.

1. Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasnt fully recovered just yet

   April 23, 2024 7:30:15 PM

   Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.

   Published by : CNBC on MSN

2. Boundless Bio boldly goes public with $100M IPO

   March 28, 2024 10:40:00 AM

   Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...

   Published by : FierceBiotech

3. Contineum lowers expectations for $110M IPO as J&J-allied biotech goes public

   April 5, 2024 10:30:00 AM

   Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...

   Published by : FierceBiotech

4. Acelyrin raises $540 million in rare biotech IPO

   May 5, 2023 3:30:00 AM

   The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...

   Published by : pharmaphorum

5. U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

   March 30, 2024 9:30:00 AM

   Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted ...

   Published by : Seeking Alpha

6. Weight loss biotech plans IPO as demand builds for anti-obesity treatments

   March 29, 2024 3:30:00 AM

   Aardvark Therapeutics, a US biotech group developing a ... The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...

   Published by : The Financial Times

7. Biotech IPOs bounced back in first quarter, but backlog remains

   April 12, 2024 3:30:00 AM

   The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter ... to tap the public markets, it shows us that there's health in the private space ...

   Published by : Yahoo Finance

8. Beyond the biotech IPO: a brave new world

   October 12, 2023 9:50:00 PM

   A commonly held perception in the biotech industry is that the sector is currently going through an acute painful malaise: no initial public offerings (IPOs ... went public on US exchanges ...

   Published by : Nature

9. What�s Congress going to do with WuXi?

   March 29, 2024 3:30:00 AM

   the latest biotech IPO, and intrigue over Chinese outsourcing. Damian Garde covered biotech, was a co-writer of The Readout newsletter, and was a co-host of "The Readout LOUD" podcast.

   Published by : STAT

10. Evolving paradigms in biotech IPO valuations

    March 2, 2015 9:11:00 AM

    2000 was a record year for biotechnology financing. In all, 63 IPOs were completed in the US, raising $5.4 billion. The average IPO proceeds soared to $85 million, after moving within the $20�30 ...

    Published by : Nature

11. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

    April 4, 2024 3:30:00 AM

    Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...

    Published by : Yahoo Finance

12. EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings

    March 21, 2024 6:34:00 PM

    Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...

    Published by : Benzinga.com

Indo US BioTech IPO Alerts